drug: fosphenytoin
- Clinical class: anticonvulsant
- CSA schedule: none
- DEA number: none
- Active metabolite: (prodrug dephosphorilated by alkaline phosphatase to) phenytoin
U.S. Preparations:
- Cerebyx® (Pfizer) FDA
approved: parenteral administration for control of generalized convulsive status
epilepticus and prevention and treatment of seizures occurring during
neurosurgery 1996 U.S. Prescribing information
